Europe
Clinical News
Informatics
Industry News
Practice Management
Education
Subspecialties
More
Sign In
Board Review
CME
Careers
Cases
Conferences
Videos
Webinars
Podcast Network
Advertising
Buyer's Guide
Vendors
Minnies
RPT Tracker
Resources
SIIM: Quality management needed for successful use of imaging AI
By
Amerigo Allegretto
A keynote given at the SIIM-ACR Data Science Summit shared how quality management is important in using imaging AI.
June 9, 2026
PET reveals brain receptor deficits in schizophrenia
By
Will Morton
The study confirms that deficits in M1 receptor are present in a subgroup of schizophrenia patients.
June 4, 2026
AI-driven cardiac PET attenuation correction shows promise
By
Kate Madden Yee
The algorithm could offer a âpractical alternative in cardiac PET,â researchers noted.
June 3, 2026
Legacy vs. Cloud-Based vs. Cloud-Native PACS- What Modern Imaging Centers Need to Know
Legacy vs. Cloud-Based vs. Cloud-Native PACS
June 3, 2026
ASCO: With help from AI, interventions boost lung cancer screening
By
Erik L. Ridley
Screening rate increased sharply over six years at the 17-hospital health system.
June 3, 2026
SNMMI: PET reveals new brain activity in multiple sclerosis
By
Will Morton
Understanding how and where certain brain connections are lost can help explain the symptoms patients experience.
June 2, 2026
SNMMI: New PET platform guides real-time bone cancer margin assessment
By
Kate Madden Yee
The approach has the potential to reshape surgical practice for osteosarcoma by allowing for precise tumor resection.
June 2, 2026
SNMMI names officers for 2026â2027 term
By
AuntMinnie.com staff writers
Society of Nuclear Medicine and Molecular Imaging leaders take office.
June 2, 2026
SNMMI: Incoming president talks meeting highlights, previews next year
By
Kate Madden Yee
AuntMinnie.com
interviewed incoming SNMMI president Heather Jacene, MD.
June 2, 2026
SNMMI: Biomarkers predict I-131 response in obese thyroid cancer patients
By
Kate Madden Yee
Metabolic status should be considered in post-therapy evaluation of obese differentiated thyroid cancer patients, researchers noted.
June 2, 2026
SNMMI: Theranostic approach may treat PSMA-negative prostate cancer
By
Amerigo Allegretto
A theranostic approach could help improve PET imaging for neuroendocrine prostate cancer care.
June 2, 2026
ASCO: Use of GLP-1 drugs linked to lower breast cancer cases
By
Erik L. Ridley
A large retrospective study found sharply lower incidence of breast cancer among women who had received GLP-1 drugs.
June 2, 2026
Page 1 of 752
Next Page
![(A-C) Representative whole-body maximum-intensity projection images and regional fused PET/CT images from three histologically confirmed osteosarcoma patients who underwent paired [68Ga]Ga-B7-H3-BCH PET/CT and 18F-FDGE PET/CT within seven days. (D) Multimodal imaging evaluation of Patient Three, including x-ray, MRI (T2-weighted imaging, T2WI), CT, and B7-H3 PET/CT.](https://img.auntminnie.com/mindful/smg/workspaces/default/uploads/2026/05/mei.XUQJWkpAJI.jpg?auto=format%2Ccompress&dpr=2&fit=crop&h=167&q=70&w=250)
![RET-targeted PET tracer highlights neuroendocrine prostate cancer tumors. Representative PET imaging shows strong tumor uptake of the RET-binding peptide tracer [âśâ¸Ga]Ga-DOTA-RET-L7 in a neuroendocrine prostate cancer (NEPC) model, supporting highly specific, high-contrast detection.](https://img.auntminnie.com/mindful/smg/workspaces/default/uploads/2026/05/screenshot-2026-05-27-205827.278Ys6PYU3.png?auto=format%2Ccompress&dpr=2&fit=crop&h=167&q=70&w=250)
